See inside every stock. Pro
S&P 5007,663▼ 1.21%Nasdaq26,009▼ 2.60%Dow Jones52,868▲ 0.02%Nasdaq 10028,959▼ 2.90%VIX19.03▲ 14.09%US Dollar101.62▼ 0.16%Gold spot4,093▼ 0.80%WTI100.23▲ 0.76%
← SCHW page
XStocksXray
Research report · 22 October 2026

Schwab Charles Corp (SCHW)

Financials · Investment Banking & Brokerage · US stock · price as of 22 Oct 2026

Key indicators

Price$91.44
52-week range$83.96 – $114.53
Market cap$159.0B
P/E (trailing)129.7×
Dividend yield1.3%
Revenue (last 12 months)$26.0B
Revenue growth (3y a year)4.8%
Price / book3.2×
Return on equity2.5%

Fair value

Fair value (average of valid models)$117.47 middle half of models $108 – $120
Versus priceUndervalued+29% to fair value
P/E multiple$108.46
P/B multiple$88.93
P/S multiple$118.77
Dividend discount, stable$119.53
Dividend discount, multi-stage$151.66
Model uncertaintyMedium

X-Ray Score

68/ 100 · Medium confidence · ahead of 97% of sector peers
Valuation72
Growth59
Profitability70
Financial health78
Dividends50

Five-year price chart navy: price · brown: 200-day average · blue band: fair value range

40.5761.4382.29103124Fair value $1172021-102023-012024-042025-072026-10

Executive summary

Charles Schwab is a brokerage and banking firm that provides investment accounts, trading, retirement services, banking and wealth management to individual investors and independent advisors. It earns money mainly from net interest revenue on client cash and loans, from asset management fees, and from trading and related services. Client assets and interest rate levels are significant drivers of results.

Looking at the top line, revenue was $26.0 billion for the latest twelve months and it grew by 4.8% a year over three years. Operating margin was 50.2%, and return on invested capital is 31%. Shareholders receive a dividend with a yield of 1.3%.

StocksXray gives Schwab Charles Corp an X-Ray Score of 68 out of 100 (medium confidence), ahead of 97% of the S&P 500 stocks in its sector. Its strongest lens is financial health (78) and its weakest is dividends (50).

Our fair value (the average of the valid models) is $117.47 (range $108.46 to $119.53). At $91.44 the stock trades 22% below that value, so the label is "Undervalued" with medium model uncertainty. Fair value is a range, not a price target.

stocksxray.com · page 1
XStocksXray
Schwab Charles Corp (SCHW)

Valuation history multiples at each fiscal year-end price; the last column uses today's price and the last twelve months

FY2021FY2022FY2023FY2024FY2025Now
Price$78.84$78.92$66.32$72.40$98.93$91.44
Market cap$149.6B$149.5B$121.4B$132.8B$179.0B$159.0B
P/E27.9×22.5×26.1×24.2×21.3×129.7×
Price / book2.7×4.1×3.0×2.7×3.6×3.2×
Dividend yield0.91%1.06%1.51%1.38%1.09%1.35%

Fundamentals checklist ● 4 Good · ● 2 Average · ● 1 Bad · each check graded against the sector

Risk models

Piotroski F-Score8 of 9Good

Growth

EPS growth (3y)9.9%Average
Revenue growth (3y)4.8%Bad
Growth consistency90%Average

Valuation

Fair value vs price1.3×Good

Profitability

Return on invested capital31.3%Good
Operating margin50.2%Good
stocksxray.com · page 2
XStocksXray
Schwab Charles Corp (SCHW)

Financials US$ millions, from SEC filings; last column is the last twelve months

Income statementFY21FY22FY23FY24FY25LTM
Revenue18,52020,76218,83719,60623,92126,025
Net income675691,253
Diluted EPS ($)2.833.502.542.994.650.70
Net margin0.0%0.0%0.0%0.0%0.0%4.8%
Balance sheetFY21FY22FY23FY24FY25LTM
Total assets667,270551,772493,178479,843490,995517,266
Cash62,97540,19543,33742,08346,03040,580
Total debt26,76938,12826,12822,42824,09922,669
Equity56,26136,60840,95848,37549,42550,147
Dividend per share ($)0.720.841.001.001.081.18

Revenue and net income US$ billions: navy revenue, teal net income

FY21FY22FY23FY24FY25

Margins blue gross, teal operating, brown net

0%23%46%69%FY21FY22FY23FY24FY25

Latest quarters

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue ($M)5,5995,8516,1356,3366,4827,072
Growth vs a year earlier+18.1%+24.8%+26.6%+18.9%+15.8%+20.9%
Net income ($M)1,9092,1262,358-6,3842,4792,800
Diluted EPS ($)0.991.081.26–1.371.54
stocksxray.com · page 3
XStocksXray
Schwab Charles Corp (SCHW)

Peers in Investment Banking & Brokerage

CompanyX-Ray
SCHW · Schwab Charles Corp68
RJF · Raymond James Financial In...55
IBKR · Interactive Brokers Group,...51
GS · Goldman Sachs Group Inc49
HOOD · Robinhood Markets, Inc.45

Market Compass outlook for Financials: Favourable (71/100). It blends regime history, macro sensitivity, momentum and valuation.

Returns

1 week−2.9%
1 month−8.9%
3 months−9.0%
6 months+0.4%
1 year−1.8%
3 years+87.3%
5 years+17.0%

Technical summary

DailyStrongly bearish1 bullish · 3 neutral · 12 bearish
WeeklyBearish4 bullish · 1 neutral · 7 bearish
MonthlyBearish2 bullish · 1 neutral · 5 bearish
50-day / 200-day average$103.05 / $97.52
52-week low / high$83.96 / $114.53
Classic pivot, support and resistanceS2 90.27 · S1 90.85 · P – · R1 92.23 · R2 93.03

Recent dividends

Ex-dividend dateAmount per share
14 Aug 2026$0.3200
8 May 2026$0.3200
13 Feb 2026$0.3200
14 Nov 2025$0.2700
8 Aug 2025$0.2700
9 May 2025$0.2700
stocksxray.com · page 4
XStocksXray
Schwab Charles Corp (SCHW)

Strengths

  • Return on invested capital of 31.3% is ahead of 85% of its sector peers.
  • Operating margin of 50.2% is ahead of 84% of its sector peers.
  • Piotroski F-Score of 8 out of 9: most of the nine accounting health tests pass.
  • Has raised its dividend for 7 years in a row.

Risks and weak spots

  • Revenue growth (3y) is weak against Financials peers (4.8%).

Latest SEC filings

DateFormItems
15 Oct 20268-K2.02,9.01
12 Aug 20268-K8.01,9.01
12 Aug 2026424B5
10 Aug 2026424B5
7 Aug 202610-Q
21 Jul 20268-K2.02,9.01
29 Jun 20268-K8.01,9.01
26 Jun 2026424B5

How to read this report

Every number comes from SEC filings, end-of-day prices and the StocksXray models described on the methodology page. The X-Ray Score ranks each metric against the company's own sector. Fair value is the average of up to 15 valuation models, most of them anchored to the company's own multiples, so it stays near the price and should be read as a range, not a point. Analyst ratings, price targets and earnings-call summaries are not part of this report. Educational research, not financial advice; read the disclaimer.

stocksxray.com · page 5 · generated 23 Oct 2026